uniQure N.V. QURE now represents more than a single-program gene therapy story. Its profile is being reshaped by faster regulatory pathways, a narrower operating model and clinical work in rare neurological diseases.Those trends matter because investors are watching whether uniQure can build the ne…
Net sales rose 6.8% year-over-year in Q2 2026, with PrivX sales up 25% and EBITDA turning positive. Strategic partnerships and analyst recognition are driving growth, while leadership transitions and a shift to subscription models continue.Based on SSH Communications Security Oyj [SSH1V] Q2 2026 Au…
Adtran Holdings, Inc./ Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act]Adtran Holdings, Inc.: Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution17.07.2026 / 20:49…
The announcements reflect intensifying competition among major technology companies and governments seeking leadership in next-generation AI systems. While firms continue to push technical boundaries with increasingly capable models and products, policymakers are placing greater emphasis on governa…
The Law Offices of Frank R. Cruz continues its investigation of Alphabet Inc. (“Alphabet” or the “Company”) (NASDAQ: GOOG) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON ALPHABET INC. (GOOG), CLICK HERE TO INQU…
LOUDON, Tenn., July 17, 2026 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. NASDAQ:MBUU, a leading designer, manufacturer, and marketer of a diverse range of recreational powerboats and marine services, today announced that Malibu Boats has been named a 2026 Coolest Thing Made in Tennessee finalist.Public…
Austin, Texas, July 17th, 2026, FinanceWireFrontieras North America, an energy and environmental technology company commercializing its patented FASForm(TM) Solid Carbon Fractionation process, has appointed Rachael Crump to its board of directors and named her chair of the Audit Committee. A certif…
Cardano is trading near support as ADA investors look for a stronger reason to step back into the market.The project still has one of the most committed communities in crypto, and its development roadmap remains a central part of the long-term argument. But price action has been quieter, and trader…
Realty Income O is widening its growth playbook beyond buying properties with its balance sheet. The net-lease giant is building partnerships that bring in outside capital, open new sectors and spread risk. Recent agreements with Apollo, GIC and Cloud Capital point to a broader real estate platform…
NuvOx Therapeutics, a clinical-stage biopharmaceutical company developing oxygen therapeutics for conditions driven by hypoxia, filed for an initial public offering. The company plans to list its common stock on the NYSE American under the symbol “NUOX.” It is offering 2,860,000 shares at an antici…
uniQure N.V. QURE has surged as investors reassessed AMT-130, its lead gene therapy candidate for Huntington's disease.The question is whether the move already reflects too much optimism. Valuation, earnings quality, estimate trends and ratings point to selective caution.QURE Has Rallied Ahead of K…
FTX said it will start distributing roughly $900 million to creditors beginning at the end of the month, according to an announcement from Friday.This marks the fifth distribution for the failed crypto exchange plans on making as part of its bankruptcy. In March, FTX distributed $2.2 billion to cre…
AT&T Inc. T is scheduled to report second-quarter 2026 earnings on July 22, before the opening bell. The Zacks Consensus Estimate for revenues and earnings is pegged at $32.04 billion and 59 cents per share, respectively. The earnings estimate for AT&T for 2026 has increased 0.43% to $2.32 per shar…
uniQure N.V. QURE remains a catalyst-driven gene therapy stock, with AMT-130 shaping most of the investment debate. The program targets Huntington’s disease, an area where disease-modifying options remain absent.Recent FDA feedback, a targeted biologics license application submission in the third q…
Ripple’s win over the US Securities and Exchange Commission (SEC) had a hidden weapon. Attorney John Deaton says nearly 4,000 XRP holders helped swing the case by telling their stories to the court.Deaton represented those holders as a friend of the court. He shared how they shaped the outcome, wit…
Novartis NVS announced that the FDA has granted traditional approval to Fabhalta (iptacopan) for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.This traditional approval converts the drug's August 2024 accelerated ap…
Harmony Biosciences HRMY announced preliminary second-quarter 2026 results.The company registered a record $261 million in net product revenues from its lead drug, Wakix (pitolisant).Wakix received FDA approval in August 2019 to treat excessive daytime sleepiness (EDS) in adults with narcolepsy and…
Apple Inc. (AAPL) and the US Justice Department are reportedly in early discussions to settle a 2024 lawsuit alleging that the iPhone maker violated antitrust laws. The discussions are active, but there is no guarantee that the two sides will reach an agreement, reported Bloomberg, citing people fa…
Rhinebeck Bancorp reported an oversubscribed depositor subscription offering and expects to close its mutual-to-stock conversion on July 21, 2026.Key Highlights:Original SEC Filing: Rhinebeck Bancorp, Inc. [ RBKB ] - 8-K - Jul. 17, 2026This is an AI-powered summary. It may contain inaccuracies. Con…
Daktronics approved its 2027 executive compensation program, setting annual and long-term incentive targets for President and CEO Ramesh Jayaraman and three other named executive officers.Original SEC Filing: DAKTRONICS INC /SD/ [ DAKT ] - 8-K - Jul. 17, 2026This is an AI-powered summary. It may co…
